Unveiling VX-661: A Key CFTR Corrector for Pharmaceutical Research
In the dynamic field of pharmaceutical research, precise and high-quality chemical compounds are paramount for driving innovation. Among these critical substances is VX-661 (CAS 1152311-62-0), a potent CFTR corrector that plays a pivotal role in understanding and developing treatments for conditions like cystic fibrosis. As a leading manufacturer and supplier of this specialized pharmaceutical intermediate, we are dedicated to providing researchers with the tools they need to advance their work.
VX-661 is scientifically recognized for its ability to correct the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This mutation is the most common cause of cystic fibrosis, leading to misfolding and impaired function of the CFTR protein. By acting as a CFTR corrector, VX-661 helps to restore the proper trafficking and surface expression of this crucial protein, thereby enhancing chloride channel activity. This makes it an indispensable compound for researchers investigating the molecular mechanisms of cystic fibrosis and exploring novel therapeutic avenues.
For procurement professionals and research scientists seeking reliable sources, it is essential to partner with experienced manufacturers and suppliers. Our company, a prominent supplier of VX-661 in China, is committed to delivering products of exceptional purity and consistency. We understand the critical nature of research-grade chemicals, and our stringent quality control measures ensure that every batch of VX-661 meets the highest scientific standards. This dedication to quality means researchers can trust our product for accurate and reproducible experimental results.
When considering the purchase of VX-661, factors such as purity, CAS number verification (1152311-62-0), and supplier reliability are key. We offer competitive pricing for VX-661, making it accessible for research institutions and pharmaceutical companies globally. If you are looking to buy VX-661 or inquire about its price, our dedicated sales team is ready to assist you. We pride ourselves on being a trusted manufacturer and supplier, ensuring that your research is never delayed due to material shortages or quality concerns.
The applications of VX-661 extend beyond fundamental research; it is a vital component in drug discovery pipelines. Its efficacy as a CFTR corrector makes it an excellent candidate for preclinical studies and for combination therapies aimed at maximizing CFTR protein function. Researchers investigating therapeutic strategies for cystic fibrosis often rely on a consistent supply of high-purity VX-661 to conduct their studies effectively. As a global supplier, we ensure that this essential research chemical is available to scientists worldwide.
In conclusion, VX-661 (CAS 1152311-62-0) stands as a cornerstone compound for researchers in the pharmaceutical and biotechnology sectors. By choosing us as your VX-661 manufacturer and supplier, you are ensuring access to a high-quality, reliable product backed by extensive expertise. We invite you to contact us for a quote and sample, and experience the difference that a dedicated and professional supplier can make to your research endeavors.
Perspectives & Insights
Alpha Spark Labs
“This mutation is the most common cause of cystic fibrosis, leading to misfolding and impaired function of the CFTR protein.”
Future Pioneer 88
“By acting as a CFTR corrector, VX-661 helps to restore the proper trafficking and surface expression of this crucial protein, thereby enhancing chloride channel activity.”
Core Explorer Pro
“This makes it an indispensable compound for researchers investigating the molecular mechanisms of cystic fibrosis and exploring novel therapeutic avenues.”